BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 15193680)

  • 1. Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial.
    Lonn E; Shaikholeslami R; Yi Q; Bosch J; Sullivan B; Tanser P; Magi A; Yusuf S
    J Am Coll Cardiol; 2004 Jun; 43(12):2200-6. PubMed ID: 15193680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
    Foster RE; Johnson DB; Barilla F; Blackwell GG; Orr R; Roney M; Stanley AW; Pohost GM; Dell'Italia LJ
    Am Heart J; 1998 Aug; 136(2):269-75. PubMed ID: 9704689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular function and no clinical heart failure.
    Kjøller-Hansen L; Steffensen R; Grande P
    J Am Coll Cardiol; 2001 Apr; 37(5):1214-20. PubMed ID: 11300425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitor therapy affects left ventricular mass in patients with ejection fraction > 40% after acute myocardial infarction.
    Johnson DB; Foster RE; Barilla F; Blackwell GG; Roney M; Stanley AW; Kirk K; Orr RA; van der Geest RJ; Reiber JH; Dell'Italia LJ
    J Am Coll Cardiol; 1997 Jan; 29(1):49-54. PubMed ID: 8996294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial.
    Pfeffer MA; Greaves SC; Arnold JM; Glynn RJ; LaMotte FS; Lee RT; Menapace FJ; Rapaport E; Ridker PM; Rouleau JL; Solomon SD; Hennekens CH
    Circulation; 1997 Jun; 95(12):2643-51. PubMed ID: 9193433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): an echocardiography-based structural analysis.
    Aikawa Y; Rohde L; Plehn J; Greaves SC; Menapace F; Arnold MO; Rouleau JL; Pfeffer MA; Lee RT; Solomon SD
    Am Heart J; 2001 Feb; 141(2):234-42. PubMed ID: 11174337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular hypertrophy: a "factor of risk": mass is reversible, but is the risk?
    Frohlich ED
    J Am Coll Cardiol; 2004 Jun; 43(12):2216-8. PubMed ID: 15193682
    [No Abstract]   [Full Text] [Related]  

  • 8. The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics.
    Cowan BR; Young AA; Anderson C; Doughty RN; Krittayaphong R; Lonn E; Marwick TH; Reid CM; Sanderson JE; Schmieder RE; Teo K; Wadham AK; Worthley SG; Yu CM; Yusuf S; Jennings GL
    Clin Res Cardiol; 2009 Jul; 98(7):421-33. PubMed ID: 19347385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dual blockade of renin-angiotensin system on TGFbeta1 and left ventricular structure and function in hypertensive patients.
    Scaglione R; Argano C; Di Chiara T; Parrinello G; Colomba D; Avellone G; Donatelli M; Corrao S; Licata G
    J Hum Hypertens; 2007 Apr; 21(4):307-15. PubMed ID: 17301824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction.
    Yip GW; Wang M; Wang T; Chan S; Fung JW; Yeung L; Yip T; Lau ST; Lau CP; Tang MO; Yu CM; Sanderson JE
    Heart; 2008 May; 94(5):573-80. PubMed ID: 18208835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review: effect of angiotensin converting enzyme inhibition on left ventricular volumes and ejection fraction in patients with a myocardial infarction and in patients with left ventricular dysfunction.
    Abdulla J; Barlera S; Latini R; Kjoller-Hansen L; Sogaard P; Christensen E; Kober L; Torp-Pedersen C
    Eur J Heart Fail; 2007 Feb; 9(2):129-35. PubMed ID: 16829187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.
    Colucci WS; Kolias TJ; Adams KF; Armstrong WF; Ghali JK; Gottlieb SS; Greenberg B; Klibaner MI; Kukin ML; Sugg JE;
    Circulation; 2007 Jul; 116(1):49-56. PubMed ID: 17576868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE inhibition with ramipril improves left ventricular function at rest and post exercise in patients with stable ischaemic heart disease and preserved left ventricular systolic function.
    Willenheimer R; Rydberg E; Oberg L; Juul-Möller S; Erhardt L
    Eur Heart J; 1999 Nov; 20(22):1647-56. PubMed ID: 10543928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]).
    Cowan BR; Young AA; Anderson C; Doughty RN; Krittayaphong R; Lonn E; Marwick TH; Reid CM; Sanderson JE; Schmieder RE; Teo K; Wadham AK; Worthley SG; Yu CM; Yusuf S; Jennings GL;
    Am J Cardiol; 2009 Dec; 104(11):1484-9. PubMed ID: 19932779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute angiotensin-converting enzyme inhibition on diastolic ventricular interaction in the dilated heart.
    Pepi M; Tamborini G; Maltagliati A; Guazzi M; Berna G; Susini F; Muratori M; Celeste F
    Clin Cardiol; 2003 Sep; 26(9):424-30. PubMed ID: 14524600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease.
    Verdecchia P; Sleight P; Mancia G; Fagard R; Trimarco B; Schmieder RE; Kim JH; Jennings G; Jansky P; Chen JH; Liu L; Gao P; Probstfield J; Teo K; Yusuf S;
    Circulation; 2009 Oct; 120(14):1380-9. PubMed ID: 19770395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of ramipril on the glucose/insulin coefficient and the ventricular mass index in patients with light to moderate arterial hypertension].
    Germán Cardona-Muñoz E; Noriega-Arellano J; Hernández-Chávez A; López-Alvarado A; González-Ortiz M; Martínez-Abundis E; Delgado Hurtado JM; Ramos-Remus C; Gamez-Nava I; Ayub-Ayala M
    Arch Cardiol Mex; 2003; 73(1):24-30. PubMed ID: 12820491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).
    Bergström A; Andersson B; Edner M; Nylander E; Persson H; Dahlström U
    Eur J Heart Fail; 2004 Jun; 6(4):453-61. PubMed ID: 15182771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: results of a randomized, double-blind, parallel-group, multicenter, European study (SMILE-4).
    Borghi C; Ambrosioni E; Novo S; Vinereanu D; Ambrosio G;
    Clin Cardiol; 2012; 35(7):416-23. PubMed ID: 22707187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.